Skip to content
OpenCapital
Get started

Phathom Pharmaceuticals, Inc. PHAT Sales & Marketing

Sales & Marketing at other companies

AMP
Amphastar PharmaceuticalsAMPH
$11.93M+0.5%

Segments

By segment

See full
Reportable Segment Aggregation Before Other Operating$42.24M-48.1%

Other financials

Income statement

See full
Revenue$58.3M+104%
Gross profit$46.3M+86.8%
Operating income-$15.5M+80.4%
Net income-$30.4M+67.8%
EPS (diluted)-$0.37+71.8%

Balance sheet

See full
Cash & equivalents$180.9M-14.8%
Total debt$166.3M-18.3%
Total equity-$337.0M+0.4%
Total assets$305.1M+3.7%

Cash flow

See full
Operating cash flow-$15.6M+81.6%
CapEx$61.0K+239%
Free cash flow-$15.7M+81.5%

Valuation

See full
Market cap$824.68M+13.4%
Enterprise value$810.08M+12.7%
P/S4×-4.9×

Profitability

See full
Gross margin84.9%-1.3pp
Operating margin-47.1%-21.9pp
Net margin-76.8%-34.5pp
FCF margin-47.7%-22.1pp

Returns & leverage

See full
Return on equity-147.9%—
Debt / equity5.6×—
Current ratio2.2×-1.4×

Questions, answered.

What does sales & marketing mean?
Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.